KVÅKVÅ3E00X05 — Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X0M — Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E0130M — Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0230M — Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
KVÅKVÅ3E0300M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach
KVÅKVÅ3E0330M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E0400M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
KVÅKVÅ3E0430M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach
KVÅKVÅ3E0500M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach
KVÅKVÅ3E0530M — Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach
KVÅKVÅ3E0600M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach
KVÅKVÅ3E0630M — Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach
KVÅKVÅ3E0930M — Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach
KVÅKVÅ3E0970M — Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening
KVÅKVÅ3E0A30M — Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach
KVÅKVÅ3E0B70M — Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening
KVÅKVÅ3E0C70M — Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening
KVÅKVÅ3E0D30M — Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach
KVÅKVÅ3E0D705 — Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening
KVÅKVÅ3E0D70M — Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening
KVÅKVÅ3E0DX0M — Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach
KVÅKVÅ3E0E305 — Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach
KVÅKVÅ3E0E30M — Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach
KVÅKVÅ3E0E705 — Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening
KVÅKVÅ3E0E70M — Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening
KVÅKVÅ3E0E805 — Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0E80M — Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0F30M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach
KVÅKVÅ3E0F705 — Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0F70M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0F805 — Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0F80M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
